• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Multicenter and multimodal imaging study reveals rare fundus lesions in patients after SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Jun 22;14(1):14369.
doi: 10.1038/s41598-024-65216-9. Multicenter and multimodal imaging study reveals rare fundus lesions in patients after SARS-CoV-2 infection

Guangqi An[SUP] 1 2 [/SUP], Bo Lei[SUP] 3 4 [/SUP], Zhili Wang[SUP] 3 [/SUP], Kaizhuan Yang[SUP] 5 [/SUP], Dongsheng Fan[SUP] 6 [/SUP], Bing Li[SUP] 7 [/SUP], Ke Fu[SUP] 8 [/SUP], Haixin Fang[SUP] 1 [/SUP], Min Zhang[SUP] 1 2 [/SUP], Lin Li[SUP] 1 [/SUP], Yu Zhao[SUP] 1 [/SUP], Xuemin Jin[SUP] 9 10 [/SUP], Liping Du[SUP] 11 12 [/SUP]



Affiliations
Abstract

To define the characteristics of fundus manifestations in patients after SARS-CoV-2 infection with multimodal imaging techniques. This is a retrospective multicenter and multimodal imaging study including 90 patients. All patients with a visual complaint occurring immediately after SARS-CoV-2 infection were referred to six clinics between December 2022 and February 2023. Demographic information and the temporal relationship between SARS-CoV-2 infection and visual symptoms were documented. The characteristics of the fundus lesions were evaluated using multimodal imaging. Ninety patients from six hospitals were included in this study, including 24 males (26.67%) and 66 (73.33%) females. Seventy-eight patients (86.66%) (146 eyes) were diagnosed with Acute Macular Neuroretinopathy (AMN). The AMN patients were primarily young women (67.95%). Sixty-eight patients (87.18%) had AMN in both eyes. Thirty-eight eyes (24.36%) included Purtscher or Purtscher-like lesions. optical coherence tomography and infrared retinal photographs can show AMN lesions well. Eleven cases were diagnosed with simple Purtscher or Purtscher-like retinopathy (2 cases, 2.22%), Vogt‒Koyanagi‒Harada (VKH) syndrome or VKH-like uveitis (3 cases, 3.33%), multiple evanescent white-dot syndrome (MEWDS) (2 cases, 2.22%), and rhino-orbital-cerebral mucormycosis (ROCM) (5 cases, 5.56%). After SARS-CoV-2 infection, diversified fundus lesions were evident in patients with visual complaints. In this report, AMN was the dominant manifestation, followed by Purtscher or Purtscher-like retinopathy, MEWDS, VKH-like uveitis, and ROCM.

Keywords: Acute macular neuroretinopathy; COVID-19; Multimodal Imaging; Retina; SARS-CoV-2.

 
Back
Top Bottom